Erratum zu: FOLFIRINOX beim duktalen Adenokarzinom des PankreasErratum to: FOLFIRINOX for pancreatic ductal adenocarcinoma

被引：0
|
作者：
Hakan Alakus
Michael Korenkov
Fabian Kütting
Christiane Bruns
机构：
[1] Universitätsklinikum Köln (AöR),Klinik und Poliklinik für Allgemein‑, Viszeral
[2] Universitätsklinikum Köln, und Tumorchirurgie
来源：
Der Onkologe | 2019年 / 25卷 / 8期
关键词：
D O I：
10.1007/s00761-019-0615-0
中图分类号：
学科分类号：
摘要：
Erratum zu:
引用
收藏
页码：728 / 728
相关论文
共 50 条
  • [21] A new chapter in adjuvant treatment of pancreatic ductal adenocarcinoma - modified FOLFIRINOX as the new standard of care
    Kawecki, Maciej
    ONCOLOGY IN CLINICAL PRACTICE, 2018, 14 (04): : 239 - 240
  • [22] Safety and efficacy of neoadjuvant FOLFIRINOX treatment in a series of patients with borderline resectable pancreatic ductal adenocarcinoma
    Tinchon, Christoph
    Hubmann, Eva
    Pichler, Angelika
    Keil, Felix
    Pichler, Martin
    Rabl, Hans
    Uggowitzer, Martin
    Jilek, Kurt
    Leitner, Gerhard
    Bauernhofer, Thomas
    ACTA ONCOLOGICA, 2013, 52 (06) : 1231 - 1234
  • [23] Dose intensity and initial treatment effect of FOLFIRINOX supported with pegfilgrastim for patients with pancreatic ductal adenocarcinoma
    Kido, H.
    Terashima, T.
    Yamashita, T.
    Takatori, H.
    Kitamura, K.
    Kaneko, S.
    ANNALS OF ONCOLOGY, 2017, 28
  • [24] Alterations in Driver Genes Are Associated with Response to Neoadjuvant Folfirinox in Patients with Nonmetastatic Pancreatic Ductal Adenocarcinoma
    Ecker, Brett L.
    Janssen, Quisette
    Tao, Alice
    Tansey, Wesley
    D'Angelica, Michael
    Drebin, Jeffrey A.
    Jarnagin, William R.
    Kingham, T. Peter
    Soares, Kevin
    Wei, Alice C.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2021, 233 (05) : S139 - S139
  • [25] Impact of Sarcopenia on Patients with Localized Pancreatic Ductal Adenocarcinoma Receiving FOLFIRINOX or Gemcitabine as Adjuvant Chemotherapy
    Mortier, Victor
    Wei, Felix
    Pellat, Anna
    Marchese, Ugo
    Dohan, Anthony
    Brezault, Catherine
    Barat, Maxime
    Fuks, David
    Soyer, Philippe
    Coriat, Romain
    CANCERS, 2022, 14 (24)
  • [26] Organoids Derived from Neoadjuvant FOLFIRINOX Patients Recapitulate Therapy Resistance in Pancreatic Ductal Adenocarcinoma
    Farshadi, Elham Aida
    Chang, Jiang
    Sampadi, Bharath
    Doukas, Michail
    Van 't Land, Freek
    van der Sijde, Fleur
    Vietsch, Eveline E.
    Pothof, Joris
    Koerkamp, Bas Groot
    van Eijck, Casper H. J.
    CLINICAL CANCER RESEARCH, 2021, 27 (23) : 6602 - 6612
  • [27] FOLFIRINOX regulated tumor immune microenvironment to extend the survival of patients with resectable pancreatic ductal adenocarcinoma
    Wu, Meng-Yao
    Shen, Meng
    Xu, Meng-Dan
    Yu, Zheng-Yuan
    Tao, Min
    GLAND SURGERY, 2020, 9 (06) : 2125 - +
  • [28] Molecular targets for diagnostic and intraoperative imaging of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX treatment
    Vuijk, F. A.
    de Muynck, L. D. A. N.
    Ranken, L. C. F.
    Busch, O. R.
    Wilmink, J. W.
    Besselink, M. G.
    Bonsing, B. A.
    Bhairosingh, S. S.
    Kuppen, P. J. K.
    Mieog, J. S. D.
    Sier, C. F. M.
    Vahrmeijer, A. L.
    Verheij, J.
    Farina-Sarasqueta, A.
    Swijnenburg, R. J.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [29] Molecular targets for diagnostic and intraoperative imaging of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX treatment
    F. A. Vuijk
    L. D. A. N. de Muynck
    L. C. Franken
    O. R. Busch
    J. W. Wilmink
    M. G. Besselink
    B. A. Bonsing
    S. S. Bhairosingh
    P. J. K. Kuppen
    J. S. D. Mieog
    C. F. M. Sier
    A. L. Vahrmeijer
    J. Verheij
    A. Fariňa-Sarasqueta
    R. J. Swijnenburg
    Scientific Reports, 10
  • [30] Prognostic value of the TP53 mutation in patients with pancreatic ductal adenocarcinoma receiving FOLFIRINOX
    Kim, Min Kyu
    Cho, In Rae
    Kim, Yooeun
    Choi, Jin Ho
    Jung, Kwangrok
    Kim, Jaihwan
    Kim, Sheehyun
    Yun, Hongseok
    Yoon, Jeesun
    Oh, Do-Youn
    Kim, Kwangsoo
    Lee, Sang Hyub
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
12345